Cargando…
The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients
BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248442/ https://www.ncbi.nlm.nih.gov/pubmed/28103814 http://dx.doi.org/10.1186/s12866-017-0933-6 |
_version_ | 1782497267725369344 |
---|---|
author | Millares, Laura Bermudo, Guadalupe Pérez-Brocal, Vicente Domingo, Christian Garcia-Nuñez, Marian Pomares, Xavier Moya, Andrés Monsó, Eduard |
author_facet | Millares, Laura Bermudo, Guadalupe Pérez-Brocal, Vicente Domingo, Christian Garcia-Nuñez, Marian Pomares, Xavier Moya, Andrés Monsó, Eduard |
author_sort | Millares, Laura |
collection | PubMed |
description | BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was obtained by 16S rRNA gene amplification and sequencing, and functional capabilities through PICRUSt. RESULTS: Thirteen patients with severe asthma were included and provided 11 bronchial biopsies (BB) and 12 bronchial aspirates (BA) suitable for sequence analyses. Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria showed relative abundances (RAs) over 5% in BB, a cutoff that was reached by Streptococcus and Prevotella at genus level. Legionella genus attained a median RA of 2.7 (interquartile range 1.1–4.7) in BB samples. In BA a higher RA of Fusobacteria was found, when compared with BB [8.7 (5.9–11.4) vs 4.2 (0.8–7.5), p = 0.037], while the RA of Proteobacteria was lower in BA [4.3 (3.7–6.5) vs 17.1 (11.2–33.4), p = 0.005]. RA of the Legionella genus was also significantly lower in BA [0.004 (0.001–0.02) vs. 2.7 (1.1–4.7), p = 0.005]. Beta-diversity analysis confirmed the differences between the microbial communities in BA and BB (R(2) = 0.20, p = 0.001, Adonis test), and functional analysis revealed also statistically significant differences between both types of sample on Metabolism, Cellular processes, Human diseases, Organismal systems and Genetic information processing pathways. CONCLUSIONS: The microbiota in the bronchial mucosa of severe asthma has a specific pattern that is not accurately represented in bronchial secretions, which must be considered a different niche of bacteria growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0933-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5248442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52484422017-01-25 The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients Millares, Laura Bermudo, Guadalupe Pérez-Brocal, Vicente Domingo, Christian Garcia-Nuñez, Marian Pomares, Xavier Moya, Andrés Monsó, Eduard BMC Microbiol Research Article BACKGROUND: The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was obtained by 16S rRNA gene amplification and sequencing, and functional capabilities through PICRUSt. RESULTS: Thirteen patients with severe asthma were included and provided 11 bronchial biopsies (BB) and 12 bronchial aspirates (BA) suitable for sequence analyses. Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria showed relative abundances (RAs) over 5% in BB, a cutoff that was reached by Streptococcus and Prevotella at genus level. Legionella genus attained a median RA of 2.7 (interquartile range 1.1–4.7) in BB samples. In BA a higher RA of Fusobacteria was found, when compared with BB [8.7 (5.9–11.4) vs 4.2 (0.8–7.5), p = 0.037], while the RA of Proteobacteria was lower in BA [4.3 (3.7–6.5) vs 17.1 (11.2–33.4), p = 0.005]. RA of the Legionella genus was also significantly lower in BA [0.004 (0.001–0.02) vs. 2.7 (1.1–4.7), p = 0.005]. Beta-diversity analysis confirmed the differences between the microbial communities in BA and BB (R(2) = 0.20, p = 0.001, Adonis test), and functional analysis revealed also statistically significant differences between both types of sample on Metabolism, Cellular processes, Human diseases, Organismal systems and Genetic information processing pathways. CONCLUSIONS: The microbiota in the bronchial mucosa of severe asthma has a specific pattern that is not accurately represented in bronchial secretions, which must be considered a different niche of bacteria growth. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12866-017-0933-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-19 /pmc/articles/PMC5248442/ /pubmed/28103814 http://dx.doi.org/10.1186/s12866-017-0933-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Millares, Laura Bermudo, Guadalupe Pérez-Brocal, Vicente Domingo, Christian Garcia-Nuñez, Marian Pomares, Xavier Moya, Andrés Monsó, Eduard The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title | The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title_full | The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title_fullStr | The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title_full_unstemmed | The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title_short | The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients |
title_sort | respiratory microbiome in bronchial mucosa and secretions from severe ige-mediated asthma patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248442/ https://www.ncbi.nlm.nih.gov/pubmed/28103814 http://dx.doi.org/10.1186/s12866-017-0933-6 |
work_keys_str_mv | AT millareslaura therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT bermudoguadalupe therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT perezbrocalvicente therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT domingochristian therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT garcianunezmarian therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT pomaresxavier therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT moyaandres therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT monsoeduard therespiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT millareslaura respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT bermudoguadalupe respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT perezbrocalvicente respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT domingochristian respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT garcianunezmarian respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT pomaresxavier respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT moyaandres respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients AT monsoeduard respiratorymicrobiomeinbronchialmucosaandsecretionsfromsevereigemediatedasthmapatients |